Tscan Therapeutics shares owned by Baker Bros. Advisors
Quarter-by-quarter ownership of Tscan Therapeutics (TCRX) shares owned by Baker Bros. Advisors
from 13F filings
Historical chart of Baker Bros. Advisors investment in Tscan Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Tscan Therapeutics held by Baker Bros. Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Tscan Therapeutics by Baker Bros. Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $14M | 2.8M | 4.98 |
| 2024-06-30 | $16M | 2.8M | 5.85 |
| 2024-03-31 | $22M | 2.8M | 7.94 |
| 2023-12-31 | $16M | 2.8M | 5.83 |
| 2023-09-30 | $7.1M | 2.8M | 2.56 |
| 2023-06-30 | $7.0M | 2.8M | 2.50 |
| 2023-03-31 | $5.8M | 2.8M | 2.10 |
| 2022-12-31 | $4.3M | 2.8M | 1.55 |
| 2022-09-30 | $8.5M | 2.8M | 3.05 |
| 2022-06-30 | $8.8M | 2.8M | 3.14 |
| 2022-03-31 | $4.0M | 1.4M | 2.80 |
| 2021-12-31 | $6.4M | 1.4M | 4.50 |
| 2021-09-30 | $12M | 1.4M | 8.34 |